SCHEMBL2575016

SCHEMBL2575016

CCCCCCCCCCCCCCCCC(C(=O)O)[n+]1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.49
GPR84 Q9NQS5 7/20 0.48
FFAR1 O14842 2/20 0.48
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
PPARD Q03181 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
ABCB11 O95342 1/20 0.41
ESR1 P03372 1/20 0.41
PGR P06401 1/20 0.41
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD1 P21728 1/20 0.41
TBXA2R P21731 1/20 0.41
ACHE P22303 1/20 0.41
PTGS1 P23219 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5531402 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5538410 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5533507 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5532409 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5535373 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5533237 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5535310 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5533710 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5532648 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5533797 1.00 ACE2 (0.49) ACE2GPR84FFAR1MAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1925719-B1 ANTIBACTERIAL FIBER, METHOD FOR PRODUCTION OF THE FIBER, ANTIBACTERIAL FIBER PRODUCT COMPRISING THE ANTIBACTERIAL FIBER, METHOD FOR PRODUCTION OF THE PRODUCT, AND METHOD FOR REGENERATION OF THE PRODUCT ALCARE CO LTD (JP) 2011-11-09 EP disclosed
US-7858106-B2 Antimicrobial fiber and its production method, and antimicrobial fiber product comprising the antimicrobial fiber, its production method and regeneration method ALCARE CO., LTD. (JP) 2010-12-28 US disclosed
US-20100113537-A1 ANTIMICROBIAL FIBER AND ITS PRODUCTION METHOD, AND ANTIMICROBIAL FIBER PRODUCT COMPRISING THE ANTIMICROBIAL FIBER, ITS PRODUCTION METHOD AND REGENERATION METHOD ALCARE CO., LTD. (JP) 2010-05-06 US disclosed
EP-1925719-A1 ANTIBACTERIAL FIBER, METHOD FOR PRODUCTION OF THE FIBER, ANTIBACTERIAL FIBER PRODUCT COMPRISING THE ANTIBACTERIAL FIBER, METHOD FOR PRODUCTION OF THE PRODUCT, AND METHOD FOR REPRODUCTION OF THE PRODUCT Alcare Co., Ltd. (JP) 2008-05-28 EP disclosed
US-20070044831-A1 Electrolyte composition and dye-sensitized solar cell NATIONAL UNIVERSITY CORPORATION KYUSHU INSTITUTE OF TECHNOLOGY (JP) 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113537-A1 ANTIMICROBIAL FIBER AND ITS PRODUCTION METHOD, AND ANTIMICROBIAL FIBER PRODUCT COMPRISING THE ANTIMICROBIAL FIBER, ITS PRODUCTION METHOD AND REGENERATION METHOD CAPG, ZFR, CETP ACE2 2244/4885GPR84 4527/4885FFAR1 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.